Newsletter | September 26, 2023

09.26.23 -- Using AI In Drug Discovery Isn't The Golden Solution You Think It Is — Yet

FEATURED EDITORIAL

Using AI In Drug Discovery Isn’t The Golden Solution You Think It Is — Yet.

By Neil Dhawan and Jason Pontin, Totus Medicines

Before we realize the true potential of advanced artificial intelligence (AI) and machine learning (ML) technologies to treat disease, we need to start by developing technologies that can generate the massive amounts of reliable, high-quality biological data that make up the fundamentals of any AI/ML approach.

INDUSTRY INSIGHTS

Harness High-Quality PBPK Modeling To Enhance Clinical Readiness

Article | By Deanna Mudie, Ph.D., Lonza, and John DiBella, Simulations Plus

Advancements in PBPK modeling are enabling drug sponsors to identify poor absorption properties early in development, helping them to mitigate risk in their preclinical and clinical studies.

How Collaborative Value Engineering Enhances The CDMO Relationship

Article | By Adam Hopper, Cambrex

Regular assessments of a partnership’s value in terms of supply chain, operational efficiency, data analysis, and more can optimize and extend the product life cycle.

Simultaneous Spray Drying For Large/Small Molecule Combinations

Q&A | Lonza

Gain insights into a “simul-spray” process pioneering for combining small and large molecules into a single, atomized drug product for inhalation administration.

Defining A Process For Your Unique mRNA

Infographic | Sartorius

Define a process for your unique mRNA with this interactive guide to pDNA, mRNA, and LNP. Overcome challenges with solutions that can help you develop a next-generation production strategy.

Approaching IND: What To Consider In Early Development

Webinar | Cambrex

When preparing for IND submission, developers must consider multiple components. Explore tips for optimizing early development programs and the benefits of housing all activities under one roof.

Addressing Key Challenges Of High-Concentration Formulation Development

Webinar | Lonza

High-concentration formulations often present challenges with regard to viscosity as well as potential changes in the behavior upon stability. Discover solutions to mitigate high viscosity.

SPONSOR